Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Peter N. Huynh"'
Autor:
Peter N. Huynh, Catherine Cheng
Publikováno v:
Frontiers in Ophthalmology, Vol 4 (2024)
Cataracts, defined as any opacity in the transparent ocular lens, remain the leading cause of blindness and visual impairment in the world; however, the etiology of this pathology is not fully understood. Studies in mice and humans have found that th
Externí odkaz:
https://doaj.org/article/4ef131a2ff67433793f02c069efed1c1
Publikováno v:
Cells, Vol 11, Iss 22, p 3561 (2022)
Chemotherapy-induced neuropathic pain is a debilitating and dose-limiting side effect. Oxaliplatin is a third-generation platinum and antineoplastic compound that is commonly used to treat colorectal cancer and commonly yields neuropathic side effect
Externí odkaz:
https://doaj.org/article/165c463e528e41af82b78b74428a39c5
Autor:
J. Michael McIntosh, Baldomero M. Olivera, Fernando Fisher, Peter N. Huynh, Cheryl Dowell, Joanna Gajewiak, Fuaad Hararah, Sean Christensen
Publikováno v:
J Med Chem
Venom-derived compounds are of broad interest in neuropharmacology and drug development. α-Conotoxins are small disulfide-containing peptides from Conus snails that target nicotinic acetylcholine receptors (nAChRs) and are in clinical development fo
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2010, Iss default, Pp 65-75 (2010)
Peter N Huynh1, Lyne G Scott1, Kenny YC Kwong21Division of Allergy-Immunology, Department of Pediatrics, Los Angeles County, University of Southern California Medical Center, Los Angeles, CA, USA; 2Division of Allergy-Immunology, Department of Pediat
Externí odkaz:
https://doaj.org/article/7ea045d389564a5784daa13ffd3a113d
Publikováno v:
Marine Drugs
Volume 18
Issue 1
Volume 18
Issue 1
Chemotherapeutic drugs are widely utilized in the treatment of human cancers. Painful chemotherapy-induced neuropathy is a common, debilitating, and dose-limiting side effect for which there is currently no effective treatment. Previous studies have
Publikováno v:
Biochem Pharmacol
The α9α10 nicotinic acetylcholine receptor (nAChR) has been characterized as an effective anti-pain target that functions through a non-opioid mechanism. However, as a pentameric ion channel comprised of two different subunits, the specific targeti